Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.

Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.

BACKGROUND:The World Health Organization has endorsed the Xpert MTB/RIF assay for investigation of patients suspected of having tuberculosis (TB). However, its utility for routine TB screening and detection of rifampicin resistance among HIV-infected patients with advanced immunodeficiency enrolling...

Full description

Bibliographic Details
Main Authors: Stephen D Lawn, Sophie V Brooks, Katharina Kranzer, Mark P Nicol, Andrew Whitelaw, Monica Vogt, Linda-Gail Bekker, Robin Wood
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-07-01
Series:PLoS Medicine
Online Access:http://europepmc.org/articles/PMC3144215?pdf=render

Internet

http://europepmc.org/articles/PMC3144215?pdf=render

Similar Items